🇺🇸 FDA
Pipeline program

ORIC-114

ORIC-114-03

Phase 1 small_molecule completed

Quick answer

ORIC-114 for Food Effect in Healthy Participants is a Phase 1 program (small_molecule) at Oric Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Oric Pharmaceuticals
Indication
Food Effect in Healthy Participants
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials